336 related articles for article (PubMed ID: 26524489)
1. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
2. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
4. CoMFA, CoMSIA, and docking studies on thiolactone-class of potent anti-malarials: identification of essential structural features modulating anti-malarial activity.
Roy KK; Bhunia SS; Saxena AK
Chem Biol Drug Des; 2011 Sep; 78(3):483-93. PubMed ID: 21672165
[TBL] [Abstract][Full Text] [Related]
5. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
[TBL] [Abstract][Full Text] [Related]
6. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
7. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
Ojha PK; Roy K
Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
[TBL] [Abstract][Full Text] [Related]
8. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
9. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
12. Binding site analysis of CCR2 through in silico methodologies: docking, CoMFA, and CoMSIA.
Kothandan G; Gadhe CG; Madhavan T; Cho SJ
Chem Biol Drug Des; 2011 Jul; 78(1):161-74. PubMed ID: 21294847
[TBL] [Abstract][Full Text] [Related]
13. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
[TBL] [Abstract][Full Text] [Related]
14. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
16. CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents.
Deshpande S; Jaiswal S; Katti SB; Prabhakar YS
SAR QSAR Environ Res; 2011; 22(5-6):473-88. PubMed ID: 21598193
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
Patel PD; Patel MR; Kaushik-Basu N; Talele TT
J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
Mondal C; Halder AK; Adhikari N; Jha T
Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
[TBL] [Abstract][Full Text] [Related]
19. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
[TBL] [Abstract][Full Text] [Related]
20. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]